Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Axsome Therapeutics Q3 Loss Narrows, Revenue Increases - Shares Up Pre-Bell

Axsome Therapeutics Q3 Loss Narrows, Revenue Increases - Shares Up Pre-Bell

MT newswireMT newswire2026/11/02 11:17
07:17 AM EST, 11/02/2026 (MT Newswires) -- Axsome Therapeutics (AXSM) reported a Q3 loss Monday of $0.25 per basic and diluted share, narrowing from a loss of $0.94 a year earlier. Analysts polled by FactSet expected losses of $0.63. Revenue for the quarter ended Sept. 30 was $259.7 million, up from $171.0 million a year earlier. Analysts expected $249.2 million. Axsome Therapeutics shares were up 5.9% in premarket trading.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!